| General Information of Drug Metabolite (DM) (ID: DM019649) |
| DM Name |
HU10
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
MT-1303
|
[1] |
|
Cytochrome P450 4F12 (CYP4F12)
|
DME0135
|
| Unclear - Unclear |
MT-1303
|
[1] |
|
Cytochrome P450 4F2 (CYP4F2)
|
DME0025
|
| Unclear - Unclear |
MT-1303
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| MT-1303 |
DR3344
|
Phase 2 |
Crohn disease |
|
|
| References |
| 1 |
Absorption, disposition and metabolic pathway of amiselimod (MT-1303) in healthy volunteers in a mass balance study
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
